Tempus AI
TEM
70.35
-1.63
-2.26%
Tempus AI
US · TEM
#1138 by market cap
Listed 2024
70.35
-1.63
-2.26%
Live - 5344 symbols - heartbeat 69s ago
· 2026-10-08 06:48
Pre-market
68.90
-2.06%
After-hours
70.25
-0.14%
Overnight
69.29
-1.51%
- Market cap
- 12.69B
- P/E (TTM)i
- -48.85
- P/Bi
- 28.53
- EPSi
- -1.41
- Div yieldi
- 0.00%
- 52W posi
- 52%
Reader sentiment
Are you bullish or bearish on TEM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 5.4 percentage points.
Institutional ownership
- Held by institutions
- 59.73% -5.41pp
- Institutions
- 572 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund40.69%
Individual/Insider34.66%
Public Company10.54%
Hedge Fund2.99%
Private Company2.91%
Family Office/Trust0.94%
Government Pension Fund0.77%
Sovereign Wealth Fund0.54%
VC/PE Fund0.15%
Other5.81%
Top holders
Eric Lefkofsky
22.52%
Bradley Keywell
7.12%
ARK Investment Management LLC
5.55%
BlackRock
4.60%
Baillie Gifford
4.54%
Kimberly Keywell
4.47%
Vanguard Capital Management, LLC
3.14%
SoftBank Group Corp.
3.00%
Vanguard Portfolio Management, LLC
2.72%
Amova Asset Management
2.27%
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 10 buys · 40 sells
| Name | Role | Stake |
|---|---|---|
| Eric Lefkofsky | Co-Founder, CEO, President & Chairman | 22.52% |
| Bradley Keywell | Co-Founder | 7.12% |
| Kimberly Keywell | -- | 4.47% |
| Ryan Fukushima | Chief Operating Officer | 0.34% |
| Peter Barris | Independent Director | 0.06% |
| Theodore Leonsis | Independent Director | 0.04% |
| Andrew Polovin | General Counsel | 0.02% |
| Erik Phelps | Executive VP, Assistant Secretary, Chief Administrative & Legal Officer | 0.01% |
| Tom Schoenherr | CEO of Ambry Genetics | 0.01% |
| Ryan Bartolucci | Chief Accounting Officer | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-24 | Tom Schoenherr | CEO of Ambry Genetics | Automatic Disposition | -10,281 | $85.00 |
| 2026-09-21 | Eric Lefkofsky | Co-Founder, CEO, President & Chairman | Automatic Disposition | -242,500 | $76.57–78.86 |
| 2026-09-16 | Eric Lefkofsky | Co-Founder, CEO, President & Chairman | Automatic Disposition | -192,500 | $80.52–81.09 |
| 2026-09-16 | Ryan Bartolucci | Chief Accounting Officer | Automatic Disposition | -7,062 | $75.00 |
| 2026-09-16 | Andrew Polovin | General Counsel | Automatic Disposition | -2,951 | $75.00 |
| 2026-09-15 | Ryan Fukushima | Chief Operating Officer | Automatic Disposition | -700 | $70.00 |
| 2026-08-31 | David Epstein | Independent Director | Automatic Disposition | -250 | $65.55 |
| 2026-08-31 | Jennifer Doudna | Independent Director | Automatic Disposition | -676 | $65.55 |
| 2026-08-31 | Ryan Fukushima | Chief Operating Officer | Automatic Disposition | -30,846 | $62.12–64.63 |
| 2026-08-27 | Nadja West | Independent Director | Automatic Disposition | -3,000 | $69.00 |
| 2026-08-20 | Tom Schoenherr | CEO of Ambry Genetics | Open Market Disposition | -2,694 | $70.00 |
| 2026-08-20 | Ryan Fukushima | Chief Operating Officer | Open Market Disposition | -14,286 | $70.00 |
| 2026-08-18 | Tom Schoenherr | CEO of Ambry Genetics | Automatic Disposition | -8,082 | $55.97–61.23 |
| 2026-08-18 | Andrew Polovin | General Counsel | Automatic Disposition | -7,927 | $56.00 |
| 2026-08-18 | James Rogers | Chief Financial Officer | Automatic Disposition | -26,313 | $60.00 |
| 2026-08-17 | Eric Lefkofsky | Co-Founder, CEO, President & Chairman | Open Market Disposition | -132,591 | $49.61 |
| 2026-08-17 | Tom Schoenherr | CEO of Ambry Genetics | Open Market Disposition | -9,232 | $49.61 |
| 2026-08-17 | Ryan Fukushima | Chief Operating Officer | Open Market Disposition | -41,095 | $49.61 |
| 2026-08-17 | Ryan Bartolucci | Chief Accounting Officer | Open Market Disposition | -6,175 | $49.61 |
| 2026-08-17 | Andrew Polovin | General Counsel | Open Market Disposition | -22,148 | $49.61 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:48:58 · For reference only, not investment advice and not tailored to your situation.